Allied Biotech Corporation

TWO:1780 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$77.96 Million
NT$2.58 Billion TWD
Market Cap Rank
#21442 Global
#1176 in Taiwan
Share Price
NT$26.80
Change (1 day)
-0.56%
52-Week Range
NT$23.45 - NT$26.95
All Time High
NT$26.95
About

Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharm… Read more

Market Cap & Net Worth: Allied Biotech Corporation (1780)

Allied Biotech Corporation (TWO:1780) has a market capitalization of $77.96 Million (NT$2.58 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21442 globally and #1176 in its home market, demonstrating a 3.47% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Allied Biotech Corporation's stock price NT$26.80 by its total outstanding shares 96243000 (96.24 Million).

Allied Biotech Corporation Market Cap History: 2026 to 2026

Allied Biotech Corporation's market capitalization history from 2026 to 2026. Data shows growth from $77.96 Million to $77.96 Million (0.00% CAGR).

Allied Biotech Corporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Allied Biotech Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 1780 by Market Capitalization

Companies near Allied Biotech Corporation in the global market cap rankings as of March 19, 2026.

Key companies related to Allied Biotech Corporation by market ranking:

  • Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
  • Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
  • Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#410 Zoetis Inc NYSE:ZTS $53.52 Billion $121.68
#434 Haleon plc NYSE:HLN $49.87 Billion $10.60
#457 Takeda Pharmaceutical Co. Ltd. PINK:TKPHF $47.47 Billion $30.07
#721 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $28.19 Billion CN¥55.11

Allied Biotech Corporation Historical Marketcap From 2026 to 2026

Between 2026 and today, Allied Biotech Corporation's market cap moved from $77.96 Million to $ 77.96 Million, with a yearly change of 0.00%.

Year Market Cap Change (%)
2026 NT$77.96 Million --

End of Day Market Cap According to Different Sources

On Mar 18th, 2026 the market cap of Allied Biotech Corporation was reported to be:

Source Market Cap
Yahoo Finance $77.96 Million USD
MoneyControl $77.96 Million USD
MarketWatch $77.96 Million USD
marketcap.company $77.96 Million USD
Reuters $77.96 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.